山东大学学报（医学版） ›› 2017, Vol. 55 ›› Issue (11): 93-96.doi: 10.6040/j.issn.1671-7554.0.2017.396
• 病例报道 • 上一篇
吴倩1,倪阳2,杨清锐1,孙红胜1
中图分类号:
| [1] | Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease[J]. Mod Pathol, 2012, 25(9): 1181-1192. |
| [2] | Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by auto immune abnormality. Proposal of concept autoimmune pancreatitis[J]. Dig Dis Sci, 1995, 40(7): 1561-1568. |
| [3] | Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis[J]. N Engl J Med, 2001, 345(2): 732-738. |
| [4] | Hamanou H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis[J]. Lancet, 2002, 359(9315): 1403-1404. |
| [5] | Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease[J]. J Gastroenterol, 2003, 38(10): 982-984. |
| [6] | Kamisawa T, Okamoto A, Kamisawa T, et al. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease[J]. J Gastroenterol, 2006, 41(7): 613-625. |
| [7] | Takahashi H, Yamamoto M, Suzuki C, et al. The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity[J]. Autoimmun Rev, 2010, 9(9): 591-594. |
| [8] | 曹雅楠, 韦欣, 丁慧, 等. IgG4相关性疾病患者异常实验室结果的分析[J]. 中华检验医学杂志, 2017, 40(2):143-145. CAO Yanan, WEI Xin, DING Hui, et al. Interpretation of abnormal laboratory test results in patients with IgG4 related disease[J]. Chin J Lab Med, 2017, 40(2): 143-145. |
| [9] | Della-Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related disease[J]. Clin Exp Immunol, 2015, 181(2): 191-206. |
| [10] | Takeuchi M, Sato Y, Ohno K, et al.T helper 2 and regulatory T-cell cytokine production by mast cells: a key factor in the pathogenesis of IgG4-related disease[J]. Mod Pathol, 2014, 27(8): 1126-1136. |
| [11] | Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients[J]. Arthritis Rheumatol, 2015, 67(9): 2466-2475. |
| [12] | Fragoulis GE, Moutsopoulos HM. IgG4 syndrome: old disease, new perspective[J]. J Rheumatol, 2010, 37(7): 1369-1370. |
| [13] | Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders[J]. Ann Rheum Dis, 2009, 68(8): 1310-1315. |
| [14] | Kamisawa T, Chen PY, Tu Y, et al. Pancreatic cancer with a high serum IgG4 concentration[J]. World J Gastroenterol, 2006, 12(38): 6225-6228. |
| [15] | Moriyama M, Ohta M, Furukawa S, et al. The diagnostic utility of labial salivary gland biopsy in IgG4-related disease[J]. Mod Rheumatol, 2016, 26(5): 725-729. |
| [16] | Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease(IgG4-RD), 2011[J]. Mod Rheumatol, 2012, 22(1): 21-30. |
| [17] | Umeda M, Fujikawa K, Origuchi T, et al. A case of IgG4-related pulmonary disease with rapid improvement[J]. Mod Rheumatol, 2012, 22(6): 919-923. |
| [18] | Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations[J]. Radiology, 2009, 251(1): 260-270. |
| [19] | 张宇, 黄少祥, 许建春,等. 肺部受累的IgG4相关性疾病1例并文献复习[J]. 重庆医学, 2016, 45(32):4604-4606. |
| [20] | 张伟, 薛峰, 刘孟春, 等. 36例IgG4相关性疾病的临床分析[J]. 中华肾脏病杂志, 2016, 32(4): 253-258. ZHANG Wei, XUE Feng, LIU Mengchun, et al. Clinical analysis of 36 cases of IgG4-related disease[J]. Chin J Neahrol, 2016, 32(4): 253-258. |
| [21] | Shimizu Y, Yamamoto M, Naishiro Y, et al. Necessity of early intervention for IgG4-related disease-delayed treatment induces fibrosis progression[J]. Rheumatology(Oxford), 2013, 52(4): 679-683. |
| [22] | Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-Related disease[J]. Arthritis Rheumatol, 2015, 67(7): 1688-1699. |
| [23] | Carruthers MN, Topazian MD, Khosroshahi A, et al. Rituximab for IgG4-related disease: a prospective, open-label trial[J]. Ann Rheum Dis, 2015, 74(6): 1171-1177. |
| [1] | 王洲洋,江蓓,李宪花,甄军晖,杨向东,胡昭,刘广义,裴斐. 感染性心内膜炎、急性肾损伤伴PR3-ANCA阳性患者1例报道[J]. 山东大学学报 (医学版), 2022, 60(2): 60-64. |
| [2] | 陈诗鸿. 糖皮质激素性骨质疏松症研究进展[J]. 山东大学学报 (医学版), 2021, 59(6): 33-37. |
| [3] | 徐大霞,侯楠,李晓峰,王闯,孔猛,焦广俊,陈允震. 糖皮质激素性骨质疏松症骨代谢与糖皮质激素用药时间的相关性[J]. 山东大学学报（医学版）, 2017, 55(5): 103-107. |
| [4] | 张岩. 某医院2014年上半年住院科室 糖皮质激素使用情况调查分析[J]. 山东大学学报（医学版）, 2014, 52(S2): 108-111. |
| [5] | 刘海俊, 谢敏妍, 陈锦华, 冯洁萍, 邓振波. 替普瑞酮对大剂量激素 治疗患者上消化道的保护作用[J]. 山东大学学报（医学版）, 2014, 52(S2): 57-58. |
| [6] | 唐琳娜，吴大玮，杨洁，卢海宁，张帆，韩辉，郭海鹏. 不同剂量地塞米松对脓毒症小鼠肺组织糖皮质激素受体-α表达及肺损伤的影响[J]. 山东大学学报(医学版), 2013, 51(10): 19-23. |
| [7] | 谭林,李莎莎,高学武. 抗病毒联合糖皮质激素和血浆置换早期干预肝衰竭倾向乙肝患者观察[J]. 山东大学学报(医学版), 2012, 50(3): 90-92. |
| [8] | 古林涛1，2，王海波1，李建峰1，韩月臣1，刘闻闻1，毛彦妍1. 病毒性面瘫小鼠脾脏糖皮质激素受体表达的研究[J]. 山东大学学报(医学版), 2012, 50(3): 44-. |
| [9] | 苏玉玲1，曲莉莉1 ，侯桂华2. 黄芪注射液对同种移植小鼠糖皮质激素受体及移植物生存的影响[J]. 山东大学学报(医学版), 2011, 49(7): 86-. |
| [10] | 姜振，王海波，李建峰，韩月臣，徐磊，刘闻闻，毛彦妍. 糖皮质激素受体在小鼠单纯疱疹病毒性面瘫中的表达变化[J]. 山东大学学报(医学版), 2011, 49(5): 43-47. |
| [11] | 薛宁，王纪文,张洪伟. 大剂量甲泼尼龙冲击治疗重症手足口病的意义[J]. 山东大学学报(医学版), 2010, 48(3): 106-. |
| [12] | 杨琳红，王珺，陈文靖，李家曌. 联合吸入糖皮质激素及长效β2-受体激动剂对COPD患者肺功能和气道炎症影响的比较[J]. 山东大学学报(医学版), 2010, 48(11): 113-. |
| [13] | 黄萍 凌霄. HPLC/MS/MS法测定抗风湿中药制剂中糖皮质激素类化学药[J]. 山东大学学报(医学版), 2009, 47(12): 138-140. |
|
